JumpCan Pharmaceutical and Its Pudilan Personal Care Brand Donate Over 600,000 RMB in Supplies to China’s Tibet, Aid Shipment Underway!
Cultural Upgrade丨JumpCan Pharmaceutical Unveils New Purpose & Values, Emphasizing Co-Building and Experience!
Recently, JumpCan Pharmaceutical officially unveiled its new purpose—"Build a joyful and vibrant life together"—alongside an updated set of six values and behaviors. This upgrade further clarifies the company’s future development direction and provides all employees with clear value-based...
Two Products of JumpCan Pharmaceutical Newly Added to 2024 National Reimbursement Drug List
On November 28, the National Healthcare Security Administration (NHSA) released the "National Reimbursement Drug List (NRDL) for Basic Medical Insurance, Work-Related Injury Insurance, and Maternity Insurance (2024)". JumpCan Pharmaceutical's Xiao'er Chiqiao Qingre Syrup (K-tonpei)...
JumpCan Pharmaceutical Wins "26th Golden Information Disclosure Award for Listed Companies"
Recently, JumpCan Pharmaceutical was honored with the "Golden Information Disclosure Award" in recognition of its outstanding performance in information disclosure, communication methods, public relations management, and investor relations management. The award was announced...
Listed Again! JumpCan Pharmaceutical Is Ranked Among "2024 Top 20 Most Competitive Listed Pharmaceutical Companies in China"
On September 25, the selection results for the "2024 Top 20 Most Competitive Listed Pharmaceutical Companies in China" were announced. Organized by the China Pharmaceutical Enterprise Association, this prestigious industry event has been held for 16 consecutive years since 2009. JumpCan...
New Achievement! JumpCan Holding Ranks 33rd in 2023 Top 100 Chinese Pharmaceutical Enterprises List
On September 7, the 41st China Pharmaceutical Industry Information Annual Conference 2024 and the "2023 Top 100 Chinese Pharmaceutical Enterprises List Release Ceremony" were held in Chengdu. During the event, the "2023 Top 100 Chinese Pharmaceutical Enterprises List" was announced, with...
JumpCan Pharmaceutical Is Approved as Taizhou's First Enterprise Offshore Innovation Center
To accelerate the formation of new quality productive forces, shape new drivers and advantages for development, and support the high-quality economic and social development of Taizhou, the Taizhou Municipal Science and Technology Bureau recently announced the recognition of JumpCan...
JumpCan Pharmaceutical's Pudilan and Tongpei Listed on 2024 China Pharmaceutical · Brand List
From June 25 to 28, the 2024 China Medical and Health Industry Symbiosis Conference (17th MHIS) were grandly held. During the event, the selection results of the "2024 China Pharmaceutical · Brand List" were announced, with JumpCan Pharmaceutical's Pudilan Xiaoyan Oral Liquid and...
Breaking News! JumpCan Pharmaceutical Wins the National Science and Technology Progress Award Again
Recently, the National Sci-Tech Conference, the National Science and Technology Award Conference, and the general assemblies of the members of the Chinese Academy of Sciences and the Chinese Academy of Engineering were grandly held in Beijing. The event honored recipients of the 2023...
JumpCan Pharmaceutical is Approved as the First in China to Produce Fexofenadine Hydrochloride for Suspension
Recently, JumpCan Pharmaceutical received the Drug Registration Certificates (Certificate No. 2024S01128 and 2024S01129) issued by the National Medical Products Administration (NMPA) for Fexofenadine Hydrochloride for Suspension in two strengths: 30mg and 15mg. This makes JumpCan...